Literature DB >> 1679370

5-HT3-like receptors in the rat medial prefrontal cortex: an electrophysiological study.

C R Ashby1, Y Minabe, E Edwards, R Y Wang.   

Abstract

In this study, we have identified and characterized 5-HT3-like receptors in the rat medial prefrontal cortex (mPFc), an area with a moderate density of 5-HT3 binding sites, using the techniques of single unit recording and microiontophoresis. The microiontophoresis of the 5-HT3 receptor agonist 2-methylserotonin (2-Me-5HT), similar to the action of 5-HT, produced a current-dependent (10-80 nA) suppression of the firing rate of both spontaneously active and glutamate (GLU)-activated (quiescent) mPFc cells. Phenylbiguanide (PBG), another 5-HT3 receptor agonist, suppressed the firing rate of mPFc cells but was less effective compared to 2-Me-5HT. The continuous iontophoresis (10-20 min) of 1 M magnesium chloride markedly attenuated the suppressant effect produced by electrical stimulation of the ascending 5-HT pathway, but did not alter 2-Me-5HT's action, suggesting that the action of 2-Me-5HT is a direct one. The suppressant action of 2-Me-5HT on mPFc cells was blocked by a number of structurally diverse and selective 5-HT3 antagonists, with a rank order of effectiveness as follows: ICS 205930 = (+/-)-zacopride greater than granisetron = ondansetron = LY 278584 greater than MDL 72222. Furthermore, the intravenous administration of (+/-)-zacopride antagonized the action of 2-Me-5HT and PBG on mPFc cells. In contrast to the effects of the 5-HT3 receptors antagonists, other receptor antagonists such as metergoline (5-HT1A,1B,1C.2), (+/-)-pindolol (5-HT1A,1B, beta), SCH 23390 (5-HT1C.2, D1), l-sulpiride (D2) or SR 95103 (GABAA) failed to block 2-Me-5HT's action. These results combined suggest that 2-Me-5HT's suppressive action on mPFc cells is mediated directly by 5-HT3-like receptors.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1679370     DOI: 10.1016/0006-8993(91)91316-s

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  11 in total

Review 1.  Regulation of GABAergic inhibition by serotonin signaling in prefrontal cortex: molecular mechanisms and functional implications.

Authors:  Zhen Yan
Journal:  Mol Neurobiol       Date:  2002 Oct-Dec       Impact factor: 5.590

2.  Presynaptic 5-HT3 receptors evoke an excitatory response in dorsal vagal preganglionic neurones in anaesthetized rats.

Authors:  Y Wang; A G Ramage; D Jordan
Journal:  J Physiol       Date:  1998-06-15       Impact factor: 5.182

Review 3.  Pharmacologic mechanisms of serotonergic regulation of dopamine neurotransmission.

Authors:  K D Alex; E A Pehek
Journal:  Pharmacol Ther       Date:  2006-10-17       Impact factor: 12.310

4.  Effect of pertussis toxin on the response of rat medial prefrontal cortex cells to the iontophoresis of serotonin receptor agonists.

Authors:  J Y Zhang; C R Ashby; R Y Wang
Journal:  J Neural Transm Gen Sect       Date:  1994

5.  Mediation by 5-HT3 receptors of an excitatory effect of 5-HT on dorsal vagal preganglionic neurones in anaesthetized rats: an ionophoretic study.

Authors:  Y Wang; A G Ramage; D Jordan
Journal:  Br J Pharmacol       Date:  1996-08       Impact factor: 8.739

6.  Sodium- and magnesium-valproate in vivo modulate glutamatergic and GABAergic synapses in the medial prefrontal cortex.

Authors:  Gabriella Gobbi; Luigi Janiri
Journal:  Psychopharmacology (Berl)       Date:  2006-02-22       Impact factor: 4.530

Review 7.  Interactions between 5-HT3 receptors and cerebral dopamine function: implications for the treatment of schizophrenia and psychoactive substance abuse.

Authors:  R M Hagan; G J Kilpatrick; M B Tyers
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

8.  Serotonin modulation of cortical neurons and networks.

Authors:  Pau Celada; M Victoria Puig; Francesc Artigas
Journal:  Front Integr Neurosci       Date:  2013-04-19

9.  Differentiated effects of the multimodal antidepressant vortioxetine on sleep architecture: Part 2, pharmacological interactions in rodents suggest a role of serotonin-3 receptor antagonism.

Authors:  Steven C Leiser; Deborah Iglesias-Bregna; Ligia Westrich; Alan L Pehrson; Connie Sanchez
Journal:  J Psychopharmacol       Date:  2015-07-14       Impact factor: 4.153

Review 10.  Serotonergic modulation of glutamate neurotransmission as a strategy for treating depression and cognitive dysfunction.

Authors:  Alan L Pehrson; Connie Sanchez
Journal:  CNS Spectr       Date:  2013-08-01       Impact factor: 3.790

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.